Literature DB >> 2565343

Circulating prosomatostatin-derived peptides. Differential responses to food ingestion.

J W Ensinck1, E C Laschansky, R E Vogel, D A Simonowitz, B A Roos, B H Francis.   

Abstract

Prosomatostatin (pro-S) and its bioactive posttranslational products, somatostatin-14 (S-14), somatostatin-13 (S-13), and somatostatin-28 (S-28), were measured in human plasma by the use of immunoglobulins to the NH2-terminus of S-28 conjugated with agarose to separate them and, thereafter, by RIA with an antiserum recognizing the COOH-terminus of pro-S, and by specific RIA for the NH2-terminus of S-14 and pro-S. In healthy men, mean basal levels of pro-S were 4 pg equivalent S-14/ml; S-14/S-13 combined were 9 pg equivalent S-14/ml; and S-28 levels were 16 pg/ml. After a 700-kcal meal, pro-S, S-14, and S-14/S-13 did not change, whereas S-28 levels doubled by 120 min and remained elevated for 240 min. To evaluate the origins of these peptides, their levels were compared in peripheral, portal, gastric, and mesenteric veins of anesthetized patients and in patients with total resection of stomach and pancreas before and after nutrient intake. The stomach and small intestine were sources of both peptides; however, most S-28 originated in the small intestine. These findings suggest that, in contrast to S-14, S-28 is a hormone and may modulate postprandial nutrient absorption and use.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565343      PMCID: PMC303864          DOI: 10.1172/JCI114055

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas.

Authors:  M P Dubois
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

2.  A STUDY OF THE ACTIVITY OF HUMAN PLASMA AMINOPEPTIDASE COMPONENTS ON DIPEPTIDES AND CHROMOGENIC SUBSTRATES.

Authors:  F J BEHAL; R D HAMILTON; F B DAWSON; L C TERRELL
Journal:  Arch Biochem Biophys       Date:  1964-11       Impact factor: 4.013

3.  The characterization of somatostatin-like immunoreactivity in human serum.

Authors:  S Kronheim; M Berelowitz; B L Pimstone
Journal:  Diabetes       Date:  1978-05       Impact factor: 9.461

4.  Release of pancreatic and gastric somatostatin-like immunoreactivity in response to the octapeptide of cholecystokinin, secretin gastric inhibitory polypeptide, and gastrin-17 in dogs.

Authors:  D Rouiller; V Schusdziarra; V Harris; R H Unger
Journal:  Endocrinology       Date:  1980-08       Impact factor: 4.736

5.  A sensitive radioimmunoassay for immunoreactive somatostatin in extracted plasma: measurement and characterization of portal and peripheral plasma in the rat.

Authors:  Y C Patel; T Wheatley; D Fitz-Patrick; G Brock
Journal:  Endocrinology       Date:  1980-07       Impact factor: 4.736

6.  Somatostatin in hypothalamus, extrahypothalamic brain, and peripheral tissues of the rat.

Authors:  Y C Patel; S Reichlin
Journal:  Endocrinology       Date:  1978-02       Impact factor: 4.736

7.  Determination of immunoreactive somatostatin in rat plasma and responses to arginine, glucose and glucagon infusion.

Authors:  M Utsumi; H Makimura; K Ishihara; S Morita; S Baba
Journal:  Diabetologia       Date:  1979-11       Impact factor: 10.122

8.  Regional distribution of blood flow in awake heat-stressed baboons.

Authors:  J R Hales; L B Rowell; R B King
Journal:  Am J Physiol       Date:  1979-12

9.  Development and validation of a specific radioimmunoassay for somatostatin in human plasma.

Authors:  E Penman; J A Wass; A Lund; P J Lowry; J Stewart; A M Dawson; G M Besser; L H Rees
Journal:  Ann Clin Biochem       Date:  1979-01       Impact factor: 2.057

10.  Splanchnic somatostatin: a hormonal regulator of nutrient homeostasis.

Authors:  V Schusdziarra; E Zyznar; D Rouiller; G Boden; J C Brown; A Arimura; R H Unger
Journal:  Science       Date:  1980-02-01       Impact factor: 47.728

View more
  11 in total

1.  Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease.

Authors:  A Lianne Messchendorp; Edwin M Spithoven; Niek F Casteleijn; Wendy A Dam; Jacob van den Born; Wouter F Tonnis; Carlo A J M Gaillard; Esther Meijer
Journal:  BMC Nephrol       Date:  2018-12-19       Impact factor: 2.388

2.  Endogenous somatostatin-28 modulates postprandial insulin secretion. Immunoneutralization studies in baboons.

Authors:  J W Ensinck; R E Vogel; E C Laschansky; D J Koerker; R L Prigeon; S E Kahn; D A D'Alessio
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

3.  Expression of peptide receptors in human endocrine tumours of the pancreas.

Authors:  C Tang; I Biemond; C B Lamers
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

4.  Plasma somatostatin-like immunoreactivity and somatostatin-28 levels in obese men.

Authors:  M Peracchi; F Carola; F Cavagnini; R Benti; B Bareggi; G Baccalaro; G Basilisco
Journal:  J Endocrinol Invest       Date:  1998-01       Impact factor: 4.256

5.  Transgenic mice overproducing islet amyloid polypeptide have increased insulin storage and secretion in vitro.

Authors:  C B Verchere; D A D'Alessio; R D Palmiter; S E Kahn
Journal:  Diabetologia       Date:  1994-07       Impact factor: 10.122

6.  Elevated circulating somatostatin levels in acromegaly.

Authors:  M Arosio; S Porretti; P Epaminonda; C Giavoli; C Gebbia; C Penati; P Beck-Peccoz; M Peracchi
Journal:  J Endocrinol Invest       Date:  2003-06       Impact factor: 4.256

7.  Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas.

Authors:  C Tang; I Biemond; G J Offerhaus; W Verspaget; C B Lamers
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35).

Authors:  Peter R van Dijk; Gijs W D Landman; Larissa van Essen; Joachim Struck; Klaas H Groenier; Henk J G Bilo; Stephan J L Bakker; Nanne Kleefstra
Journal:  BMC Endocr Disord       Date:  2015-04-14       Impact factor: 2.763

Review 9.  The Cells of the Islets of Langerhans.

Authors:  Gabriela Da Silva Xavier
Journal:  J Clin Med       Date:  2018-03-12       Impact factor: 4.241

Review 10.  Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men.

Authors:  Patrik Rorsman; Frances M Ashcroft
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.